PLAT and androgen insensitivity syndrome: In a recent study of AIS patients receiving IV tPA, 20% of patients showed fibrinogen degradation coagulopathy defined as a fibrinogen level decrease ≥200 mg/dL at 6 h after IV tPA infusion, which was associated with increased rate of hemorrhagic complications (15).